Brian Liau

Our central goal is to develop novel chemical biology and functional genomic approaches to illuminate molecular mechanisms in epigenetics and gene regulation, while exploring the promise of chromatin regulators as therapeutic targets for cancer.

The Liau lab is building a multidisciplinary research program at the interface of chemistry, gene regulation, and epigenetics research. Layered atop the genetic code, ‘epigenetic’ chromatin modifications have been implicated in regulating cell state and are often deregulated in human disease, suggesting that intervention in these pathways may hold great promise for potential therapeutic applications. However, the underlying molecular mechanisms that govern these epigenetic processes and gene regulation remain unclear. To address this, we are developing novel chemical biology and functional genomic approaches to illuminate such molecular mechanisms, while exploring the promise of chromatin regulators as therapeutic targets for cancer. Technology development will blend chemistry with molecular and cell biology, and downstream applications and studies will integrate functional genomics and cancer biology.